The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2027

Conditions
Hydrocephalus, CommunicatingHydrocephalus
Interventions
DEVICE

eShunt™ Implant

The eShunt™ Implant is designed to drain excess cerebrospinal fluid (CSF) from the intracranial subarachnoid space (SAS) into the venous system as a minimally invasive treatment for communicating hydrocephalus.

Trial Locations (1)

C1426B

RECRUITING

Clínica La Sagrada Familia, Buenos Aires

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

AlvaMed, Inc.

INDUSTRY

collaborator

Bioscience Consulting, Inc.

INDUSTRY

collaborator

Simplified Clinical Data Systems, LLC

INDUSTRY

lead

CereVasc Inc

INDUSTRY

NCT04758611 - The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt) | Biotech Hunter | Biotech Hunter